Zhang Wanke, Meng Hua, Li Zhen-Hua, Shu Zhenju, Ma Xiuye, Zhang Bin-Xian
Geriatric Research, Education, and Clinical Center, South Texas Veterans Health Care System, Audie L. Murphy Division, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
Am J Physiol Renal Physiol. 2007 Mar;292(3):F1054-64. doi: 10.1152/ajprenal.00286.2006. Epub 2006 Nov 7.
It has been shown that store-operated Ca(2+) influx (SOC) plays critical roles in the activation of endothelial nitric oxide (NO) synthase (eNOS) and generation of NO in endothelial cells. Recent studies indicate stromal interaction molecule 1 (STIM1) is the molecule responsible for SOC activation following Ca(2+) depletion in the ER. Retinoic acids (RA) have beneficial effects in the treatment of renal diseases. The mechanism of the RA action is still largely unknown. In the current study, we used primary cultured rat mesangial cells to examine the effect of RA on SOC and STIM1. In these cells, BK caused concentration-dependent Ca(2+) mobilization. Treatment of the cells with RA, while it had no effect on the initial peak, reduced the plateau phase of BK-mediated Ca(2+) response, indicating the inhibition of SOC by RA. The level of STIM1 protein but not mRNA in RA-treated cells was significantly reduced. RA treatment did not affect TGF-beta-mediated gradual Ca(2+) influx which occurred by superoxide anion-mediated mechanism, indicating RA treatment specifically inhibited SOC in mesangial cells. RT-PCR and Western blot analysis demonstrated that eNOS was expressed in rat mesangial cells grown in media containing 11 and 30 but not 5.5 mM glucose. Downregulation of STIM1 protein and BK-induced SOC by RA treatment or STIM1 dsRNA were associated with abolished NO production. The 26S proteasome inhibitor lactacystin blocked the RA-mediated downregulation of BK-induced SOC, suggesting that ubiquitin-proteasome pathway may be involved in RA-mediated STIM1 protein downregulation in rat mesangial cells. Our data suggest that glucose-induced eNOS expression and NO production in mesangial cells may contribute to hyperfiltration in diabetes and RA may exert beneficial effects by downregulation of STIM1 and SOC in mesangial cells.
研究表明,钙库操纵性钙离子内流(SOC)在内皮型一氧化氮合酶(eNOS)激活及内皮细胞一氧化氮(NO)生成过程中发挥关键作用。近期研究表明,基质相互作用分子1(STIM1)是内质网中钙离子耗竭后负责激活SOC的分子。视黄酸(RA)在肾脏疾病治疗中具有有益作用。RA作用的机制仍 largely 未知。在本研究中,我们使用原代培养的大鼠系膜细胞来检测RA对SOC和STIM1的影响。在这些细胞中,BK引起浓度依赖性的细胞内钙离子(Ca(2+))动员。用RA处理细胞,虽然对初始峰值无影响,但降低了BK介导的Ca(2+)反应的平台期,表明RA抑制了SOC。RA处理细胞中STIM1蛋白水平显著降低,但mRNA水平未受影响。RA处理不影响转化生长因子-β(TGF-β)介导的由超氧阴离子介导机制发生的逐渐钙离子内流,表明RA处理特异性抑制系膜细胞中的SOC。逆转录-聚合酶链反应(RT-PCR)和蛋白质印迹分析表明,eNOS在含11和30而非5.5 mM葡萄糖的培养基中生长的大鼠系膜细胞中表达。通过RA处理或STIM1双链RNA下调STIM1蛋白和BK诱导的SOC与NO生成的消除相关。26S蛋白酶体抑制剂乳胞素阻断了RA介导的BK诱导的SOC下调,提示泛素-蛋白酶体途径可能参与RA介导的大鼠系膜细胞中STIM1蛋白下调。我们的数据表明,葡萄糖诱导的系膜细胞中eNOS表达和NO生成可能导致糖尿病中的高滤过,而RA可能通过下调系膜细胞中的STIM1和SOC发挥有益作用。